Acquired Fanconi's syndrome associated with tenofovir therapy

Journal of General Internal Medicine

Volumn 21, Issue 11, 2006, Pages

  Mathew, George ^a,c   Knaus, Stephen J ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST VINCENT HOSPITAL   (United States)

^c Division of Critical Care Medicine   (United States)

Author keywords

Fanconi's syndrome; HIV; Renal tubular acidosis; Tenofovir

Indexed keywords

EFAVIRENZ; LAMIVUDINE; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; ELECTROLYTE INTAKE; FANCONI RENOTUBULAR SYNDROME; FOLLOW UP; HUMAN; KIDNEY FAILURE; LABORATORY TEST; MALE; MYALGIA; PHYSICAL EXAMINATION; REHYDRATION; TREATMENT OUTCOME;

ADENINE; ADULT; FANCONI SYNDROME; HUMANS; MALE; PHOSPHONIC ACIDS;

EID: 33749416028     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2006.00518.x     Document Type: Article

References (20)

1. Verhelst D, Monge M, Meynard J, et al. Fanconi's syndrome and renal failure induced by tenofovir: a first case report. Am J Kidney Dis. 2002;40:1331-33.
2. Creput C, Gonzalez-Canali G, Hill G, Piketty C, Kazatchkine M, Nochy D. Renal lesions in HIV-1-positive patient treated with tenofovir. AIDS. 2003;17:935-7.
3. Karras A, Lafaurie M, Furco A, et al. Tenofovir-related nephrotoxicity in human Immunodeficiency virus-infected patients: three cases of renal failure, Fanconi's syndrome and nephrogenic diabetes insipidus. Clin Infect Dis. 2003;36:1070-73.
4. Reynes J, Peyriere H, de Merle Boever C, Le Moing V. Renal tubular injury and severe hypophosphotemia (Fanconi's syndrome) associated with tenofovir therapy. 10th CROI, Seattle. February 9-14, 2002. Abstract 717.
5. James CW, Steinhaus MC, Szabo S, Dressler RM. Tenofovir-related nephrotoxicity: case report and review of the literature. Pharmacotherapy. 2004;24:414-8.
6. Peyrière H, Reynes J, Rouanet I, Daniel N, Merle de Boever C. Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J AIDS. 2004;35:269-73.
7. Earle KE, Seneviratne T, Shaker J, Sboback D. Fanconi's syndrome in HIV+ adults: report of three cases and literature review. J Bone Miner Res. 2004;19:714.
8. Lacy M, Gertz M. Acquired Fanconi's syndrome associated with monoclonal gammopathies. Hem/Oncol Clin N Am. 1999;13:1273-80.
9. Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Drug-induced Fanconi's syndrome. Am J Kidney Dis. 2003;41:292-309.
10. Baum M. The cellular basis of Fanconi syndrome. Hosp Practice. 1993;137-48.
11. Zanoteli E, De Oliveira AS, Tengan CH, Morita MP, Schmidt B, Gabbai AA. Distal renal tubular acidosis presenting with rhabdomyolysis. Arquivos de Neuro-Psiquiatra. 1994;52:549-53.
12. Hanip M, Cheong I, Chin G, Khalid B. Rhabdomyolysis associated with hypokalemic periodic paralysis of renal tubular acidosis. Singapore Med J. 1990;31:159-61.
13. Melnick J, Baum M, Thompson J. Aminoglycoside-induced Fanconi's syndrome. Am J Kidney Dis. 1994;23:118-22.
14. Crowther MA, Callaghan W, Hodsman AB, et al. Dideoxyinosine-associated nephrotoxicity. AIDS. 1993;7:131-2.
15. Kahn J, Lagakos S, Wulfsohn M, et al. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA. 1999;282:2305-12.
16. Birkus G, Hitchcock MJ, Cihlar T. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother. 2002;46:716-23.
17. Gilead Marketed Products. 2005. Annual report. Available at: http://www.gilead.com. Accessed July 2, 2005.
18. Thompson M. Clinical update on antiviral drugs. ICAR, 2000. Tenofovir: GS-00-902 and GS-00-907 Studies. Foster City, CA: Gilead Sciences; 2000.
19. Brian SR, Mark AP. Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure. Am J Med. 2004;117:282-4.
20. Jones R, Stebbing J, Nelson M, Moyle G. Renal dysfunction with tenofovir-containing highly active antiretroviral therapy regimens: a cohort and case-control study. J AIDS. 2004;37:1489-95.